Literature DB >> 3758685

Regression of posterior uveal malignant melanomas after cobalt plaque radiotherapy.

J J Augsburger, B T McNeary, H von Below, J W Gamel, J A Shields, L W Brady, A M Markoe, J L Day.   

Abstract

We reviewed the records of 17 patients with posterior uveal malignant melanoma who had been followed for at least 3 months prior to cobalt plaque radiotherapy and whose tumor had been documented to enlarge in thickness during that interval. We evaluated the relationship between the rates of pretreatment tumor enlargement and post-treatment tumor shrinkage using linear regression analysis. We found that the rate of postirradiation tumor shrinkage correlated strongly with the rate of preirradiation tumor enlargement regardless of whether the pretreatment rate of growth was slow, intermediate or rapid. We speculate that the more rapidly regressing tumors were more mitotically active than their more slowly regressing counterparts. If true, the survival rate of patients whose posterior uveal malignant melanomas regress rapidly following radiation therapy may prove to be worse than that of patients whose tumors regress slowly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758685     DOI: 10.1007/bf02173352

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Malignant melanoma of the choroid treated with radioactive applicators.

Authors:  H B STALLARD
Journal:  Trans Ophthalmol Soc U K       Date:  1959

2.  The treatment of ophthalmic tumours with low-energy sources.

Authors:  R Sealy; P L le Roux; F Rapley; E Hering; D Shackleton; D Sevel
Journal:  Br J Radiol       Date:  1976-06       Impact factor: 3.039

3.  Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.

Authors:  P K Lommatzsch
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

4.  Surgical update on tumors of the posterior segment: alternatives to enucleation in the management of posterior uveal malignant melanomas at Wills Eye Hospital.

Authors:  J J Augsburger
Journal:  Trans Pa Acad Ophthalmol Otolaryngol       Date:  1982

5.  Proton irradiation of choroidal melanomas. Preliminary results.

Authors:  E S Gradoudas; M Goitein; A Koehler; I J Constable; M S Wagner; L Verhey; J Tepper; H D Suit; R J Brockhurst; R J Schneider; K N Johnson
Journal:  Arch Ophthalmol       Date:  1978-09

6.  Cobalt plaque therapy of posterior uveal melanomas.

Authors:  J A Shields; J J Augsburger; L W Brady; J L Day
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

7.  Accuracy of clinical estimates of tumor dimensions. A clinical-pathologic correlation study of posterior uveal melanomas.

Authors:  J J Augsburger; J W Gamel; R S Bailey; L A Donoso; J R Gonder; J A Shields
Journal:  Retina       Date:  1985 Winter-Spring       Impact factor: 4.256

8.  Diagnostic modalities in choroidal melanoma.

Authors:  D H Char; R D Stone; A R Irvine; J B Crawford; G F Hilton; L I Lonn; A Schwartz
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

9.  Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy.

Authors:  A F Cruess; J J Augsburger; J A Shields; L W Brady; A M Markoe; J L Day
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

10.  Helium ion charged particle therapy for choroidal melanoma.

Authors:  D H Char; J R Castro; J M Quivey; G T Chen; J T Lyman; R D Stone; A R Irvine; M Barricks; J B Crawford; G F Hilton; L I Lonn; A Schwartz
Journal:  Ophthalmology       Date:  1980-06       Impact factor: 12.079

View more
  4 in total

1.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 2.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

3.  Changes in height of choroidal melanomas after plaque therapy.

Authors:  D H Abramson; C A Servodidio; B McCormick; D Fass; E Zang
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

4.  Regression patterns of choroidal melanoma: After palladium-103 (103Pd) plaque brachytherapy.

Authors:  Abhilasha Maheshwari; Paul T Finger
Journal:  Eur J Ophthalmol       Date:  2018-05-22       Impact factor: 2.597

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.